Living Well with Prostate Cancer

CureTalks

APRIL 21, 2017

UPCOMING /Recent Talks

Living Well with Prostate Cancer

with Dr. Paul Schellhammer

April 24th, 2017. 6PM EST

Quality of life is a major concern of patients when they are choosing treatment for prostate cancer. Our prostate cancer panel led by Mike Scott is talking to Dr. Paul Schellhammer, a prostate cancer survivor himself, about treatment outcomes and post treatment quality of life, from his own experience as a patient and 40+ years of treating prostate cancer patients.

Panelists

Dr. Paul Schellhammer

Mike Scott

Paul Carpenter

Rick Davis

Priya Menon

Immunotherapy Advances in Multiple Myeloma
with Dr. Saad Usmani

April 18th, 2017. 6PM EST

LISTEN

Recent years have seen the emergence of immunotherapy as a leading form of treatment for multiple myeloma. New strategies as monoclonal antibody therapies, antibody-drug conjugates, immune checkpoint therapy, adoptive cell therapies such as natural killer cells, marrow infiltrating lymphocytes, dendritic cells, CAR T cell therapies and cancer vaccines represent the basis for next generation myeloma therapies. We are talking to Dr. Saad Usmani of Levine Cancer Institute / Carolinas Healthcare System about the latest advances in immunotherapy for multiple myeloma.

Panelists

Dr. Saad Usmani

Gary Petersen

Yelak Biru

Cynthia Chmielewski

Matt Goldman

Developments in Personalized Medicine and New Options in Breast Cancer Treatment with Dr. Jame Abraham

March 30th, 2017. 5PM EST

LISTEN

In this era of personalized medicine the standard "one dose fits all" approach to cancer care has been ineffective leading to treatment failures. Personalized medicine is a new healthcare paradigm that allows physicians to choose treatment methodology optimally based on person's genetic or protein profiles. Our breast cancer panel is talking to Dr. Jame Abraham of Cleveland Clinic to learn about the developments in personalized medicine in breast cancer treatment. The panel will also discuss research in this field and new options available for breast cancer treatment.
Panelists